Accéder au contenu
Merck

Deglycobleomycin A6 analogues modified in the methylvalerate moiety.

Bioorganic & medicinal chemistry (2011-05-27)
Xiaoqing Cai, Paul A Zaleski, Ali Cagir, Sidney M Hecht
RÉSUMÉ

Previous studies have indicated that the methylvalerate subunit of bleomycin (BLM) plays an important role in facilitating DNA cleavage by BLM and deglycoBLM. Eleven methylvalerate analogues have been synthesized and incorporated into deglycoBLM congeners by the use of solid-phase synthesis. The effect of the valerate moiety in the deglycoBLM analogues has been studied by comparison with the parent deglycoBLM A(5) using supercoiled DNA relaxation and sequence-selective DNA cleavage assays. All of the deglycoBLM analogues were found to effect the relaxation of the plasmid DNA. Those analogues having aromatic C4-substituents exhibited cleavage efficiency comparable to that of deglycoBLM A(5). Some, but not all, of the deglycoBLM analogues were also capable of mediating sequence-selective DNA cleavage.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Methylpentanoic acid, ≥98%, FCC, FG
Sigma-Aldrich
2-Methylvaleric acid, 98%